Heron Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
HRTX Nasdaq 2830 www.herontx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Heron Therapeutics, Inc.

Heron Therapeutics sees Q4 revenue $40.5M, consensus $39.83M - Jan 10th, 2026 7:35 am
Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth - Jan 9th, 2026 7:29 am
Heron Therapeutics, Inc. (NASDAQ:HRTX) is favoured by institutional owners who hold 57% of the company - Dec 15th, 2025 6:19 am
Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV) - Dec 4th, 2025 6:15 am
Heron Therapeutics (HRTX): Forecasts Signal 60.89% Annual Earnings Growth, Path to Profitability in Focus - Nov 4th, 2025 6:16 pm
Heron Therapeutics Inc (HRTX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - Nov 4th, 2025 2:06 pm
Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Nov 4th, 2025 7:30 am
Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates - Nov 4th, 2025 7:15 am
Heron Therapeutics: Q3 Earnings Snapshot - Nov 4th, 2025 6:13 am
Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress - Nov 4th, 2025 6:00 am
Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors - Oct 29th, 2025 3:58 pm
Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 - Oct 21st, 2025 2:20 pm
Heron Therapeutics, Inc. Adopts Tax Benefits Preservation Plan to Protect NOL Assets and Shareholder Value - Aug 15th, 2025 5:45 am
Heron Therapeutics Inc (HRTX) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... - Aug 9th, 2025 1:05 am
Heron Therapeutics (HRTX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Aug 8th, 2025 7:30 am
Heron Therapeutics (HRTX) Reports Q2 Loss, Misses Revenue Estimates - Aug 8th, 2025 6:55 am
Heron Therapeutics Completes Capital Restructuring - Aug 8th, 2025 6:21 am
Heron Therapeutics: Q2 Earnings Snapshot - Aug 8th, 2025 5:52 am
Heron Therapeutics Announces Q2 2025 Financial Results and Highlights Commercial Progress - Aug 8th, 2025 5:45 am
Heron Therapeutics Announces Comprehensive Capital Restructuring to Support Growth and Extend Maturity Profile - Aug 8th, 2025 5:45 am